PRA Health Sciences Inc

PRA Health Sciences — Q3 2015 Earnings Presentation

17 slides from PRA Health Sciences's earnings presentation, Nov 2, 2015

  1. Slide 1: Forward Looking Statements and Use of Non-GAAP Financial Measures

    Forward Looking Statements and Use of Non-GAAP Financial Measures This presentation contains forward-looking statements that reflect, among other things, the Company’s current expectations and anticipated results of operations, all of which are subject to known and unknown risks, uncertainties and o

  2. Slide 2: Q3 2015 Highlights

    Q3 2015 Highlights ($ in millions) $345.1 million of service revenue; 12% constant currency growth $66.6 million of Adjusted EBITDA; 42% growth compared to prior year Adjusted Net Income per share of $0.52; 53% growth compared to prior year Q3 2015 Q3 2014 % Change Service Revenue $345.1 $320.1 7.8%

  3. Slide 3: Trailing Quarterly Performance

    Trailing Quarterly Performance Adjusted Gross Profit ($M) Adjusted EBITDA Margin (%) Service Revenue ($M) Adjusted EBITDA ($M) $96.3 $98.2 $104.5 $109.1 $113.2 $116.9 $124.2 Q1 2014 Q2 2014 Q3 2014 Q4 2014 Q1 2015 Q2 2015 Q3 2015 12.7% 14.6% 14.7% 15.6% 16.8% 18.2% 19.3% 11% 12% 13% 14% 15% 16% 17%

  4. Slide 4: Backlog and New Business Awards

    Backlog and New Business Awards Ending Backlog ($M) Backlog Conversion % Net Book-to-Bill Net New Business Awards ($M) 1.13 1.19 1.19 1.20 1.20 1.21 1.25 Q1 2014 Q2 2014 Q3 2014 Q4 2014 Q1 2015 Q2 2015 Q3 2015 $351.3 $371.9 $382.1 $388.4 $398.0 $407.8 $431.4 Q1 2014 Q2 2014 Q3 2014 Q4 2014 Q1 2015 Q

  5. Slide 5: Debt Structure

    Debt Structure Weighted Average ($ in millions) September 30, December 31, March 31, June 30, September 30, Interest Maturity 2014 2014 2015 2015 2015 Rate Date Senior debt: First Lien 881.1 $ 729.0 $ 714.0 $ 699.0 $ 689.0 $ 4.50% September 23, 2020 Senior Notes 375.0 225.0 225.0 225.0 225.0 9.50% O

  6. Slide 6: Full Year 2015 Guidance

    Full Year 2015 Guidance Original Guidance (Feb. 18, 2015) Previous Guidance (July 27, 2015) Revised Guidance Expected Service Revenue $1.35B - $1.40B $1.34B - $1.39B $1.365B - $1.37B Diluted GAAP Net Income per Share $0.60 - $0.65 $0.80 - $0.90 $1.00 - $1.05 Diluted Adjusted Net Income per Share $1.

  7. Slide 7: Full Year 2015 Guidance

    H€ | Full Year 2015 Guidance Original Previous Guidance Guidance evised (Feb. 18,2015) (July 27, 2015) Expected Service Revenue $1.35B-$1.40B $1.34B-$1.39B $1.365B - $1.37B pele EAL SL IU as $0.60 - $0.65 $0.80 - $0.90 $1.00 - $1.05 Share Sfluted Adjusted NetIncome per ¢4.35_ $1.45 $1.75 - $1.85 $1.

  8. Slide 8: Q3 and YTD 2015 Financial Results

    Q3 and YTD 2015 Financial Results ($ in millions) 2015 2014 % Change 2015 2014 % Change Service Revenue 345.1 $ 320.1 $ 7.8% 1,013.6 $ 942.8 $ 7.5% EBITDA 69.4 $ 51.0 $ 36.0% 181.9 $ 117.2 $ 55.2% Adjusted EBITDA 66.6 $ 47.0 $ 41.6% 183.7 $ 132.2 $ 38.9% Adjusted EBITDA Margin 19.3% 14.7% 18.1% 14.0

  9. Slide 9: Trailing Quarterly Performance

    Trailing Quarterly Performance Q3 15 v ($ in millions) Q3 14 % Q3 Q4 FY Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Change Service revenue 188.1 $ 298.8 $ 832.9 $ 311.4 $ 311.3 $ 320.1 $ 323.8 $ 1,266.6 $ 332.0 $ 336.5 $ 345.1 $ 7.8% % growth Y-o-Y 27.9% 91.7% 39.5% 87.0% 73.4% 70.2% 8.4% 52.1% 6.6% 8.1% 7.8% % growth

  10. Slide 10: Backlog and New Business Awards

    Backlog and New Business Awards Q3 15 v ($ in millions) Q3 14 % Q3 Q4 FY Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Change Beginning Backlog 1,444.2 $ 1,465.6 $ 1,382.8 $ 1,939.7 $ 1,987.3 $ 2,044.8 $ 2,091.5 $ 1,939.7 $ 2,141.1 $ 2,185.3 $ 2,262.4 $ Ending Backlog 1,465.6 $ 1,939.7 $ 1,939.7 $ 1,987.3 $ 2,044.8 $ 2,0

  11. Slide 11: Reconciliation of GAAP EBITDA to Adjusted EBITDA

    Reconciliation of GAAP EBITDA to Adjusted EBITDA For further information regarding the reconciliation of non-GAAP measures to their corresponding GAAP equivalent please see our press release ($ in millions) 2015 2014 2015 2014 Net income (loss) 23.7 $ 1.2 $ 53.3 $ (12.9) $ Depreciation and amortizat

  12. Slide 12: Reconciliation of GAAP Net Income (Loss) to Adjusted Net Income

    Reconciliation of GAAP Net Income (Loss) to Adjusted Net Income For further information regarding the reconciliation of non-GAAP measures to their corresponding GAAP equivalent please see our press release ($ in millions, except per share data) 2015 2014 2015 2014 Net income (loss) 23.7 $ 1.2 $ 53.3

  13. Slide 13: Reconciliation of GAAP Income from Operations to Adjusted Income from Operations

    Reconciliation of GAAP Income from Operations to Adjusted Income from Operations For further information regarding the reconciliation of non-GAAP measures to their corresponding GAAP equivalent please see our press release ($ in millions) 2015 2014 2015 2014 Income from operations 49.2 $ 17.0 $ 120.

  14. Slide 14: Geographic Breakdown

    Geographic Breakdown Region Q3 15 Q3 14 US/Canada $ 208.1 $ 193.8 Europe/Africa 104.1 96.9 Latin America 14.1 14.2 Asia/Pacific 18.8 15.1 Grand Total $ 345.1 $ 320.1 Region YTD 2015 YTD 2014 US/Canada $ 615.9 $ 562.1 Europe/Africa 304.3 299.8 Latin America 41.4 40.6 Asia/Pacific 52.1 40.4 Grand Tota

  15. Slide 15: Days Sales Outstanding

    Days Sales Outstanding ($ in millions) Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Accounts Receivable, net 141.2 $ 232.6 $ 246.0 $ 241.9 $ 236.1 $ 233.3 $ 239.6 $ 281.4 $ 281.9 $ Unbilled Services 58.3 62.3 102.3 98.0 113.2 105.5 132.8 115.2 118.5 Total Accounts Receivable and Unbilled Services 199.5 294.9 348.3 33

  16. Slide 16: Days Sales Outstanding

    | Days Sales Outstanding (Sinmions) 2013 2014 2015, 3 ae a a2 cy as a az 3 ‘Accounts Receivable, net $ M12 $ 2326 $ 260 $ 219 § 2361 § 2333 $ 2896 § 214 $ 2819 Unbilled Services 583623 1023.98 321055 1328 1152 __ 1185. Total Accounts Receivable and Unbiled Services 1995 29493483339 349.3 3388 34 396

  17. Slide 17: PRA Health Sciences

    m\/A Ws PRAHEALTHSCIENCES HE FU RE OF CLINICAL DEVELOPME

PRA Health Sciences — Q3 2015 Earnings Presentation on 6ix